[CytoReason in PharmaTimes] Momentum for Poolbeg and CytoReason’s AI collaboration
Partnership establishes several influenza therapy targets using artificial intelligence Poolbeg Pharma – a company concentrating on infectious conditions with a high unmet medical need – has announced a notable breakthrough in its world-first influenza artificial intelligence (AI) programme with CytoReason. Poolbeg has been collabroating with CytoReason since last year. Read...
Read More